Detalles de la búsqueda
1.
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
Catheter Cardiovasc Interv
; 101(6): 1134-1143, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37036268
2.
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial.
Catheter Cardiovasc Interv
; 98(6): E870-E880, 2021 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33909348
3.
Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.
Catheter Cardiovasc Interv
; 96(3): E377-E386, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31808295
4.
The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO-3 trial.
Catheter Cardiovasc Interv
; 96(7): E688-E694, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943717
5.
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trial.
Catheter Cardiovasc Interv
; 93(7): 1374-1381, 2019 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31116908
6.
Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
Catheter Cardiovasc Interv
; 90(6): 1027-1037, 2017 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28493641
7.
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
Catheter Cardiovasc Interv
; 90(6): 1016-1026, 2017 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28498562
8.
Review article: randomised controlled trials in inflammatory bowel disease-common challenges and potential solutions.
Aliment Pharmacol Ther
; 55(6): 658-669, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35132657
9.
Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial.
Clin Res Cardiol
; 110(5): 649-657, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33839885
10.
Clinical outcome and angiographic results with novel polysulfone polymer coating paclitaxel eluting stent in real-world clinical practice: a clinical centre registry.
Med Sci Monit
; 16(10): MT77-82, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20885360
11.
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial.
Int J Cardiol
; 297: 22-29, 2019 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31630816
12.
Usefulness of Clopidogrel Loading in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the BRAVO-3 Randomized Trial).
Am J Cardiol
; 123(9): 1494-1500, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30826050
13.
Impact of acute infarct-related artery patency before percutaneous coronary intervention on 30-day outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention in the EUROMAX trial.
Eur Heart J Acute Cardiovasc Care
; 7(6): 514-521, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28631502
14.
Success, safety, and efficacy of implantation of diamond-like carbon-coated stents.
Angiology
; 58(2): 203-10, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17495270
15.
One-Year Mortality for Bivalirudin vs Heparins Plus Optional Glycoprotein IIb/IIIa Inhibitor Treatment Started in the Ambulance for ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of the EUROMAX Randomized Clinical Trial.
JAMA Cardiol
; 2(7): 791-796, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28273285
16.
Bivalirudin infusion to reduce ventricular infarction: the open-label, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) study.
EuroIntervention
; 13(5): e540-e548, 2017 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28506937
17.
Cerebral Embolism During Transcatheter Aortic Valve Replacement: The BRAVO-3 MRI Study.
J Am Coll Cardiol
; 68(6): 589-599, 2016 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27208464
18.
Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support.
Circulation
; 109(24): 2986-92, 2004 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-15184289
19.
Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trial.
Circ Cardiovasc Interv
; 8(6): e002049, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26056249
20.
Acute stent thrombosis after primary percutaneous coronary intervention: insights from the EUROMAX trial (European Ambulance Acute Coronary Syndrome Angiography).
JACC Cardiovasc Interv
; 8(1 Pt B): 214-220, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25616927